与COVID-19相关的凝血病:一个图书统计调查
1Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, Jazan University, Jazan, Saudi Arabia.
Heliyon
|June 5, 2023
概括
这项文献计量研究分析了COVID-19相关凝血病 (C19-CA) 研究趋势. 它确定了关键的作者,机构和研究热点,强调了COVID-19患者的异常凝血,血栓形成和治疗策略.
科学领域:
- * 医学 * 医学
- * 生物化学 * 生物化学
- * 遗传学和分子生物学
- * 免疫学和微生物学
背景情况:
- *SARS-CoV-2感染会引发免疫血静反应.
- *在COVID-19中,过度的凝血激活会导致血栓事件和炎症.
- *了解COVID-19相关的凝血病 (C19-CA) 对于临床管理至关重要.
研究的目的:
- *对C19-CA研究进行文献计量分析.
- * 确定研究热点,趋势和该领域的关键贡献者.
- *为C19-CA.的未来研究方向提供见解.
主要方法:
- * 使用Scopus数据库进行文献数据.
- *使用类似性可视化 (VOSviewer) 软件进行文献识别映射.
- *分析了共同作者,共同引用,文献联结和关键词的共同出现.
主要成果:
- * 总共检索了2242项研究,显示出大量的出版物增长.
- * 顶级作者包括Smadja,DM,Diehl,JL和Gendron,N (法国).
- *华中科技大学 (中国) 和美国分别是领先的机构和国家.
- *主要主题包括异常凝血,肺凝血病,血栓性疾病,炎症和抗凝固药疗法.
结论:
- *图书统计分析有效地绘制了C19-CA研究的格局.
- * 确定了领先的研究人员,机构和新兴研究主题.
- *为未来对C19-CA及其管理的调查提供了基础.
相关概念视频
Coagulation
335
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
335
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
16
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
16
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
15
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
15
Anticoagulant Drugs: Low-Molecular-Weight Heparins
767
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
767
Blood Transfusion and Agglutination
10.9K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.9K


